Interestingly, up-regulated transcription of Fibromodulin clearly segregates B-CLL from other B and T cell leukemia, whereas Glypican-2 seems most exclusive of AML variants (Fig. 5B). This evidence concerns the gene FMOD and B-cell chronic lymphocytic leukemia.